<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="25757">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02771444</url>
  </required_header>
  <id_info>
    <org_study_id>DOC-EMOA-A7UDZ2</org_study_id>
    <nct_id>NCT02771444</nct_id>
  </id_info>
  <brief_title>Low Dose Tomosynthesis Compared to Traditional Tomosynthesis</brief_title>
  <official_title>Low Dose Tomosynthesis Compared to Traditional Tomosynthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Digital Mammography Sweden AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Digital Mammography Sweden AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate image quality of a low-dose tomosynthesis system versus a
      comparator. Subjects will undergo a four-view tomosynthesis examination with the comparator
      and with the study device, and images will be assessed by several radiologists by comparing
      details in the images from the two systems.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tomosynthesis is a relatively new technology to acquire mammographic images where images are
      acquired over several projection angles, giving 3d information that can help radiologists
      assess images.

      The aim of the study is to see whether a new low-dose tomosynthesis system has comparable
      image quality at a lower x-ray radiation dose to a comparator.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>No masking</masking>
    <masking_description>This is an imaging study. All participants will be imaged using two modalities. All participant data will be deidentified.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>X-ray dose</measure>
    <time_frame>4 months</time_frame>
    <description>X-ray dose will be measured per projection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lesion conspicuity comparison of images from study device vs comparator</measure>
    <time_frame>4 months</time_frame>
    <description>Lesion conspicuity will be assessed by image readers (radiologists) comparing the conspicuity of the same lesion imaged with the study device to the comparator</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Breast Neoplasms</condition>
  <arm_group>
    <arm_group_label>Tomo Assessment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will have a 4-view tomosynthesis examination with the study device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tomo Assessment</intervention_name>
    <description>A four-view tomosynthesis examination</description>
    <arm_group_label>Tomo Assessment</arm_group_label>
    <other_name>MicroDose Tomosynthesis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Woman over 40 years of age

          -  Has a tomosynthesis examination with comparator

          -  Has a mammographic finding

        Exclusion Criteria:

          -  Pregnant, breastfeeding or believes she may be pregnant

          -  Unable or unwilling to give informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pietro Panizza, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale San Raffaele</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pietro Panizza, M.D</last_name>
    <phone>+392 26436310</phone>
    <email>panizza.pietro@hsr.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ospedale San Rafaele</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pietro Panizza, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 3, 2017</lastchanged_date>
  <firstreceived_date>May 10, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
